Lisa Danzig named Rockefeller University’s chief investment officer

Lisa Danzig, director of investments at Rockefeller University, has been appointed vice president and chief investment officer effective July 1, President Paul Nurse has announced. More »


Rockefeller University vaccine researchers selected for grant from Foundation for NIH

A team of researchers led by Rockefeller University immunologist Ralph M. Steinman, M.D., has been selected for a grant offer from the Foundation for the NIH (FNIH) of $14 million to support the design of novel vaccines that stimulate multiple components of the body’s immune response, including those that have been difficult to target with existing vaccine approaches. More »

Tags: ,

David Rockefeller pledges $100 million to Rockefeller University

Largest gift in University’s history will support innovative science, graduate program.
More »

Tags: ,

Researchers create infectious hepatitis C virus in a test tube

New system will allow scientists to study every stage of the HCV life cycle and develop drugs to treat this life-threatening disease. More »

Tags: ,

Worming our way into the brain

Rockefeller scientists find that studying glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases. More »

Tags: ,

Rockefeller University scientist elected fellow of Royal Society

Rockefeller University’s David Gadsby, Ph.D., was elected a fellow of the Royal Society for his research into how ion transporters function, and specifically for furthering our understanding of the origins of cystic fibrosis. More »

Tags: ,

One gene links newborn neurons with those that die in diseases such as Alzheimer’s

In certain parts of the brain, cells called neurons go through a cycle of death and replenishment. New research from Rockefeller University’s Fernando Nottebohm, Ph.D., shows that these replaceable neurons share something in common with the neurons that die in people with diseases such as Alzheimer’s and Parkinson’s: both have unusually low levels of a protein called UCHL1. More »

Tags: , ,

The Starr Foundation funds tri-institution stem cell research

Three New York City biomedical research institutions — The Rockefeller University, Weill Medical College of Cornell University, and Memorial Sloan-Kettering Cancer Center (MSKCC) — will receive $50 million over three years from The Starr Foundation to develop new resources and expertise in stem cell research. More »

Tags: ,

Beyond epigenetics

Rockefeller University scientists now have moved a step beyond epigenetics in describing how genetically driven activities are carried out. Working with an important molecule, called Ezh2, known to alter histones in the cell nucleus, Sasha Tarakhovsky, Ph.D., and his colleagues have discovered a new type of signaling system in the cytosol, the fluid or jelly-like substance outside of a cell’s nucleus. More »

Tags: ,

For young canaries learning their song, freedom in youth gives way to rules in adulthood

Young canaries can learn atypical songs but recast them into adult canary syntax as they mature, a previously undescribed aspect of vocal prowess in birds. More »

Tags: ,

Two Rockefeller scientists elected to National Academy of Sciences

The National Academy of Sciences announced the election of 72 new members this morning, including two Rockefeller University scientists. More »

Tags: , ,

Vaccine developed at Rockefeller University boosts natural killer T cells in patients with cancer

A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work. More »

Tags: , , ,

Jeffrey Friedman, discoverer of leptin, receives Gairdner, Passano awards

Rockefeller University’s Jeffrey M. Friedman, M.D., Ph.D., a molecular geneticist whose discovery of the hormone leptin and its role in regulating body weight has changed our understanding of the causes of human obesity, has received two prestigious awards for this work: the Gairdner Foundation International Award and the Passano Foundation Award. More »

Tags: , ,

Rockefeller University researchers are changing the face of addiction treatment

People addicted to heroin, alcohol and other drugs of abuse often fail to stay clean because they won’t go to or won’t stay in treatment. Reporting in the January issue of the Journal of Substance Abuse Treatment, Scott Kellogg, Ph.D., and Mary Jeanne Kreek, M.D., at The Rockefeller University, and colleagues at the New York City Health and Hospitals Corporation (HHC) and at Johns Hopkins University, show that a treatment approach called contingency management improves patients’ motivation to stay in treatment and increases their therapeutic progress. More »

Tags: , ,

Mice with defective sperm offer clues to infertility in men

New research in mice by scientists at Rockefeller University and the Population Council sheds light on the causes behind male infertility. More »

Tags: ,

Renowned French neuroscientist Jean-Pierre Changeux receives Rockefeller University’s science writing prize

Jean-Pierre Changeux, Ph.D., one of the boldest thinkers in modern neuroscience, received the Rockefeller University Lewis Thomas Prize for Writing about Science Tues., March 29. More »

Tags: ,

Researchers identify gene that plays major role in age-related blindness disease

Scientists at Rockefeller University, Yale University School of Public Health and the National Eye Institute have identified a gene that confers susceptibility to age-related macular degeneration. More »

Tags: ,

“Blinding” an insect’s sense of smell may be the best repellent

Scientists have found that a single gene is responsible for the sense of smell in fruit flies, malaria mosquitoes, medfly and corn earworm moth. This information may provide a starting point for future designs of pesticides and disease-controlling insect repellents. More »

Tags: ,

Despite causes of lupus proving complex, scientists get a new lead on potential treatment

Scientists at The Rockefeller University have determined that the autoimmune disease lupus results from a combination of genetics that likely varies from person to person, and that a common “gatekeeper” gene called FCR?IIB is critical to the prevention of this devastating disease. More »

Tags: ,

Rockefeller researchers identify new role for key protein that regulates separation of DNA in dividing cells

Rockefeller University scientists have revealed a new function of a key component of the mechanism that cells use to accurately separate chromosomes when they divide. Disruptions in this process can cause diseases such as cancer. More »

Tags: , ,